TFO
ENTA icon

Tarbox Family Office’s Enanta Pharmaceuticals ENTA Stock Holding History

Tarbox Family Office’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-25
Closed -$1K – 1187
2020
Q1 		$1K Buy
25
+6
+32% +$320 ﹤0.01% 841
2019
Q4 		$1K Buy
+19
New +$1.18K ﹤0.01% 956

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Tarbox Family Office's ENTA Position: Q2 2020 in Review

Tarbox Family Office sold out of Enanta Pharmaceuticals (ENTA) in Q2 2020, closing a stake of 25 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in ENTA in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 180 funds tracked by Wall St. Rank hold ENTA as of Q2 2020.

  • Tarbox Family Office reported no remaining Enanta Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Tarbox Family Office sold 25 Enanta Pharmaceuticals shares in Q2 2020, an estimated $1K.
  • Tarbox Family Office first reported a position in Enanta Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Tarbox Family Office's Enanta Pharmaceuticals position peaked at $1K in Q1 2020.
  • 180 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2020.

Based on Tarbox Family Office's 13F filing for Q2 2020, filed 23 Jul 2020.